Promoted Content
Promoted Content

Overview of Ethanol

Client Email Product
02855_FLUKA
  • Synopsis

  • Chemistry

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

JDMFs Filed

JDMFs Filed

Other Certificates

Other Certificates

0

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)

0

API Market Place

INTERMEDIATES

0

DOSSIERs
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

0

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

Dossiers Market Place

0

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

MEDIA

Blog

News

REFERENCE STANDARD

EDQM

USP

JP

0

Other Listed Suppliers

0

SERVICES

0

ListLIST
  • FDA
  • EDQM
Applications: Pharmasperse® 416 is a versatile drug delivery system (DDS) comprised of excipients such as mannitol. It is specifically engineered to manufacture orally dispersible powder (ODP) formulations.
Ingredient(s): Mannitol
Route of Administration (Grade): Oral
Pharmacopoeia Reference: Not Available
Technical Specifications: Not Available
  • FDA
  • EDQM
  • Audit Compliance
Applications: Propyl Gallate, is an ester formed from gallic acid & propanol and is used as an antioxidant. It is used in the oral solids, mostly aimed at modulating the stability of APIs. They are used to improve the shelf life of pharmaceuticals.
Ingredient(s): Propyl Gallate
More Info on Category: API Stability Enhancers
Route of Administration (Grade): Oral, Topical
Pharmacopoeia Reference: USP, EP, ICH, Q7GMP
Technical Specifications: NA
  • FDA
  • EDQM
Applications: It offers an enteric-release profile to the upper gastro-intestinal tract that meets the disintegration requirements for delayed-release capsules for the European, US and Japanese Phamacopoeia.
Ingredient(s): HPMC AS
Dosage Form: Capsule
Route of Administration (Grade): Oral
Pharmacopoeia Reference: Complies with relevant European, Japanese and US Pharmacopeia monographs
Technical Specifications: Water content – less than 6%; Size #0
  • FDA
  • EDQM
Applications: Capsugel’s soft gelatin capsules and technologies brings a range of formulation and commercial benefits to the pharmaceutical and dietary supplement markets.
Ingredient(s): Gelatin, Unspecified
More Info on Category: Soft Gelatin
Route of Administration (Grade): Oral; Ocular; Vaginal
Pharmacopoeia Reference: Not Available
Technical Specifications: Not Available
  • FDA
Applications:
Ingredient(s): Mannitol
Dosage Form: Capsule, Tablet
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Not Available
Technical Specifications: Not Available
  • WHO-GMP
Applications: Pharmacel® 101 is a strong binder for wet & dry granulation formulations as it ensures uniform granulation and drying processes. It also provides excellent compaction and disintegration properties.
Dosage Form: Tablet
More Info on Category: Fillers, Diluents & Binders
Route of Administration (Grade): Oral
Pharmacopoeia Reference: Conforms to USP-NF, Ph.Eur., JP, IP
Technical Specifications: Density- Tapped density- 440 g/l, Bulk density- 280 g/l; Particle size- D10- 25 ?m, D50- 60 ?m, D90- 20 ?m; Hausner ratio-1,57
  • WHO-GMP
Applications: Orally Disintegrating Tablets (ODTs) / Sachets, Dispersible Tablets / Sachets, Chewable Tablets, Sublingual Tablets.
Ingredient(s): Crospovidone
Route of Administration (Grade): Oral
Pharmacopoeia Reference: Conforms to Japanese Pharmaceutical Excipients. All components meet USP-NF, JP, and EP.
Technical Specifications: Not Available
  • WHO-GMP
Applications: Ready mix Film coating system for moisture sensitive APIs
Ingredient(s): Stearic Acid
Dosage Form: Capsule, Tablet
Route of Administration (Grade): Oral
Pharmacopoeia Reference: USP / EP / JP; Having US-DMF
Technical Specifications: Moisture barrier film coating system
  • FDA
  • EDQM
Applications: Controlled Release, Direct Compression,Wet Granulation,Tablet Coating, Liquid Solutions and Suspensions
Dosage Form: Tablet, Capsule
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: Not Available
Technical Specifications: Not Available
  • FDA
Applications: Film Forming Agent, Wet/Dry Granulation- Binder,Thickening & Suspension Agent, Non-Gelatin Capsule Manufacturing & Enteric Film Coating Systems
Dosage Form: Capsule, Tablet
Route of Administration (Grade): Not Available
Pharmacopoeia Reference: USP, EP, and JP
Technical Specifications: Not Available
left grey arrow
right gray arrow
  • SOLUTION;INTRA-ARTERIAL - 99% (1ML)
  • SOLUTION;INTRA-ARTERIAL - 99% (5ML)
  • SOLUTION;TOPICAL - 61%;1%